![Hing Wong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hing Wong
Founder at
HCW BIOLOGICS INC.
Net worth: 1 M $ as of 31/05/2026
Profile
Dr. Hing C.
Wong is a Chief Executive Officer, Secretary & Director at HCW Biologics Inc. He is on the Board of Directors at HCW Biologics Inc. Dr. Wong was previously employed as a Chief Executive Officer by ImmunityBio, Inc. /Old/, a President, Chief Executive Officer & Director by Altor BioScience Corp., a Chairman & Chief Executive Officer by Sunol Molecular Corp., a Director-Biology Skills Center by Baxter International, Inc., a Director-Microbial Genetics by Cetus Corp., a Director-Microbial Genetics Department by Chiron Corp., a President & Chief Executive Officer by Altor BioScience Corp., a Trustee by Rumbaugh-Goodwin Institute For Cancer Research, Inc., and a Trustee by The Cancer Research Foundation, Inc. He also served on the board at Biosynexus, Inc. He received his doctorate degree from the University of Massachusetts.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HCW BIOLOGICS, INC. 9.14% | 22/05/2026 | 615,790 ( 9.14% ) | 1 M $ | 31/05/2026 |
Hing Wong active positions
| Companies | Position | Start |
|---|---|---|
| HCW BIOLOGICS INC. | Founder | 02/04/2018 |
Former positions of Hing Wong
| Companies | Position | End |
|---|---|---|
NantCell, Inc.
 NantCell, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for immunogenic diseases | Chief Executive Officer | 01/03/2018 |
Altor BioScience Corp.
 Altor BioScience Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops therapeutic products for the treatment of cancer | Founder | 01/08/2017 |
Sunol Molecular Corp.
 Sunol Molecular Corp. Pharmaceuticals: MajorHealth Technology Develops gel therapeutics to treat disorders associated with the human tissue factor | Chief Executive Officer | 01/01/2002 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/01/1996 |
Cetus Corp.
 Cetus Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/1992 |
Training of Hing Wong
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
67
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Altor BioScience Corp.
Altor BioScience Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops therapeutic products for the treatment of cancer | Health Technology |
Cetus Corp.
Cetus Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biosynexus, Inc.
 Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Sunol Molecular Corp.
Sunol Molecular Corp. Pharmaceuticals: MajorHealth Technology Develops gel therapeutics to treat disorders associated with the human tissue factor | Health Technology |
The Cancer Research Foundation, Inc.
 The Cancer Research Foundation, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Rumbaugh-Goodwin Institute For Cancer Research, Inc. | |
NantCell, Inc.
NantCell, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for immunogenic diseases | Health Technology |
HCW Biologics Inc.
 HCW Biologics Inc. BiotechnologyHealth Technology Develops immunotherapies for chronic, low-grade inflammation and age related disorders | Health Technology |
- Stock Market
- Insiders
- Hing Wong
